Mettl3 guides CD8 T cells to eliminate infected cells with maximum efficiency

This study is led by Dr. Shuyang Yu (College of Biological Sciences, China Agricultural University), Dr. Jingyu Xu (The Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine of Zunyi Medical University) and Dr. Xuguang Du (College of Biological Sciences, China Agricultural University) and illustrated the key role of Mettl3 in CD8 T cell response during acute infection model.

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer

Artificial intelligence-driven analysis of blood samples showed potential for early diagnosis of ovarian cancer with 93% accuracy. (Georgia Tech, Gynecologic Oncology) Hologic announced FDA clearance

February 3, 2024

California Governor Signs Minor Psychedelic Drug Reform Bill

Psychedelic drug policy saw minor reform in California over the weekend. Governor Gavin Newsom signed a bill into law on Saturday enabling California doctors to

October 4, 2023

Peloton PTON and why you should avoid Peloton PTON stock

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.